Singular Genomics Systems Inc (OMIC)
22.77
+0.02
(+0.09%)
USD |
NASDAQ |
Nov 15, 09:54
Singular Genomics Systems Cash and Short Term Investments (Quarterly): 133.20M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 133.20M |
| March 31, 2024 | 150.74M |
| December 31, 2023 | 173.94M |
| September 30, 2023 | 190.72M |
| June 30, 2023 | 206.68M |
| March 31, 2023 | 226.07M |
| December 31, 2022 | 244.58M |
| September 30, 2022 | 263.84M |
| Date | Value |
|---|---|
| June 30, 2022 | 287.49M |
| March 31, 2022 | 315.97M |
| December 31, 2021 | 339.22M |
| September 30, 2021 | 357.01M |
| June 30, 2021 | 371.67M |
| March 31, 2021 | 150.12M |
| December 31, 2020 | 26.92M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
26.92M
Minimum
Dec 2020
371.67M
Maximum
Jun 2021
229.21M
Average
226.07M
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Bruker Corp | 148.10M |
| Azenta Inc | 595.84M |
| Harvard Bioscience Inc | 4.569M |
| Bionano Genomics Inc | 18.94M |
| Akoya Biosciences Inc | 45.22M |